Back to Search
Start Over
Guanidinoacetate methyltransferase (GAMT) deficiency: a rare but treatable epilepsy.
- Source :
-
Practical neurology [Pract Neurol] 2017 Jun; Vol. 17 (3), pp. 207-211. Date of Electronic Publication: 2017 Jan 24. - Publication Year :
- 2017
-
Abstract
- Epilepsy commonly presents in childhood as part of a syndrome, and some such children may reach adult services without an underlying syndromic diagnosis. For adult neurologists taking over their care, it is often unclear how hard to search for an underlying diagnosis. The diagnostic yield may be small and such a diagnosis may not change management. Young adults with learning difficulties are also challenging to investigate, as they may not tolerate standard epilepsy tests.We present such a case in which simple tests identified a unifying diagnosis. With the new diagnosis came a new treatment that had a significant impact on seizures and quality of life.<br />Competing Interests: Competing interests: JWS has received speaker honoraria from GlaxoSmithKline, Eisai, UCB, Lundbeck and Teva and was a member of the advisory boards for UCB and Eisai. He receives research support from the Dr Marvin Weil Epilepsy Research Fund, the Epilepsy Society (UK), the Netherlands Epilepsy Fund, Eisai, GlaxoSmithKline and UCB. He serves on the editorial board of the Lancet Neurology and his current position is endowed by the Epilepsy Society (UK). EM has received unrestricted educational grant funding and travel support from Genzyme and Shire Pharmaceuticals and funding for clinical trial work from Vitaflo, Ultragenyx, Genzyme, Shire and BiomarinPharmaceuticals. JSW is supported by a Wellcome Trust Postdoctoral Training Fellowship for MB/PhD Graduates (095939) and the Wellcome Trust Centre for Neuroimaging is supported by core funding from the Wellcome Trust (091593). JHC has received (all paid to her department) research monies from Vitaflo and GW Pharma, honoraria for advisory boards from Nutricia, Shire, Takeda, Eisai and GSK, and honoraria for speaking by Nutricia, Eisai, UCB and Shire, outside the submitted work.<br /> (© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.)
- Subjects :
- Adult
Creatine blood
Creatine therapeutic use
Creatine urine
Guanidinoacetate N-Methyltransferase blood
Guanidinoacetate N-Methyltransferase genetics
Guanidinoacetate N-Methyltransferase metabolism
Guanidinoacetate N-Methyltransferase urine
Humans
Language Development Disorders genetics
Language Development Disorders metabolism
Male
Movement Disorders complications
Movement Disorders genetics
Movement Disorders metabolism
Mutation genetics
Epilepsy etiology
Epilepsy therapy
Guanidinoacetate N-Methyltransferase deficiency
Language Development Disorders complications
Movement Disorders congenital
Subjects
Details
- Language :
- English
- ISSN :
- 1474-7766
- Volume :
- 17
- Issue :
- 3
- Database :
- MEDLINE
- Journal :
- Practical neurology
- Publication Type :
- Academic Journal
- Accession number :
- 28119378
- Full Text :
- https://doi.org/10.1136/practneurol-2016-001475